A National Survey of NASH Patients Will Provide Insights on Improving Care

The Fatty Liver Foundation (FLF) has just announced a new national survey which will document the experiences and needs of individuals living with non-alcoholic fatty liver disease (NAFLD) and nonalcoholic…

Continue Reading A National Survey of NASH Patients Will Provide Insights on Improving Care
Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis
source: pixabay.com

Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis is a liver disease, causing fat to build up in the liver. The resulting inflammation may lead to liver cancer or cirrhosis (scarring) and possible liver failure. As…

Continue Reading Korean Group’s Successful Experiment to Treat Nonalcoholic Steatohepatitis
Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus
source: pixabay.com

Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus

  According to a recent article from Physician’s Weekly, two trials recently published are showing the results of striving to improve the management and outcomes in nonalcoholic steatohepatitis (NASH) and…

Continue Reading Improving NAFLD and NASH Outcomes Through Novel Drug and Histologic Spectrum Focus
We Need to Improvement the Management and Care of NAFLD and NASH
source: pixabay.com

We Need to Improvement the Management and Care of NAFLD and NASH

Rare disease patients often face obstacles when it comes to the different aspects of care, whether that's diagnosis, screening, or management. Recent research from Baylor College of Medicine investigated the…

Continue Reading We Need to Improvement the Management and Care of NAFLD and NASH

Studies Show That Sucrose May Be Partly Responsible for Chronic Liver Disease in Children

According to a recent report in Medical Xpress, over twenty studies have indicated escalating events of nonalcoholic fatty liver disease (NAFLD) in children worldwide. In the United States, NAFLD heads…

Continue Reading Studies Show That Sucrose May Be Partly Responsible for Chronic Liver Disease in Children
Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial
source: pixabay.com

Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial

According to a story from dernieresactus.fr, the biopharmaceutical company Inventiva has recently announced plans for its upcoming phase III clinical trial. This trial will investigate its lead candidate lanifibranor as…

Continue Reading Inventiva Introduces Design for its Phase III Nonalcoholic Steatohepatitis Trial